Apheresis MNC Collection
A cell bank of allogeneic γδ T cells required to ensure that an adequate supply of γδ T cells is available for research and development purposes as well as to conduct future clinical trials using γδ T cells (unmodified or modified) as IMP.
Existing samples:
- No pathologic diagnosis (finding)
Bespoke collection capabilities:
- Fit and well (finding)
Contact Information
- Email:
- a.scott@tcbiopharm.com
- Address:
-
TC BioPharm Ltd.
Maxim 1
2 Parklands Way
Holytown
Motherwell
North Lanarkshire
ML1 4WR
Scotland
Last Updated: 06/04/2020
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2016 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2017 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2018 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2025 | N/A | N/A | N/A | N/A | N/A | N/A |